Patent: 10,449,118
✉ Email this page to a colleague
Summary for Patent: 10,449,118
| Title: | Manufacture of peanut formulations for oral desensitization |
| Abstract: | The present application relates to a method for managing the development and manufacturing process of a therapeutically effective formulation. Peanut proteins are characterized from peanut flour and encapsulated formulations made using the peanut flour for oral immunotherapy of peanut allergies. |
| Inventor(s): | Walser; Bryan (Menlo Park, CA), Raff; Howard V. (Mill Valley, CA) |
| Assignee: | AIMMUNE THERAPEUTICS, INC. (Brisbane, CA) |
| Application Number: | 15/792,716 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,449,118
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Aimmune Therapeutics, Inc. | PALFORZIA | peanut (arachis hypogaea) allergen powder-dnfp | Powder | 125696 | January 31, 2020 | ⤷ Start Trial | 2037-10-24 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
